Group O human immunodeficiency virus-1 infections

Infectious Disease Clinics of North America

Volumn 12, Issue 1, 1998, Pages 39-46

  Jaffe, H W ^a   Schochetman, G ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; BLOOD TRANSFUSION; EUROPE; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; REVIEW; UNITED STATES;

EID: 0031920086     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70407-4     Document Type: Article

References (42)

1. A.W. Artenstein T.C. VanCott J.R. Mascola Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans J Infect Dis 171 1995 805
2. env immunodominant region of HIV type 1 group O from West Central Africa AIDS Res Hum Retroviruses 13 1997 901
3. C.A. Brennan J. Yamaguchi A.S. Vallari Genetic variation in human immunodeficiency virus type 2: Identification of a unique variant from human plasma AIDS Res Hum Retroviruses 13 1997 401
4. P. Charneau A.M. Borman C. Quillent Isolation and envelope sequence of a highly divergent HIV–1 isolate: Definition of a new HIV–1 group Virology 205 1994 247
5. J.M. Coffin Structure, replication, and recombination of retrovirus genomes: Some unifying hypotheses J Gen Virol 42 1979 1
6. K.M. DeCock G. Adjorlolo E. Ekpini Epidemiology and transmission of HIV–2: Why is there no HIV–2 pandemic JAMA 270 1993 2083
7. R. De Leys B. Vanderborght M. Vanden Haesevelde Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin J Virol 64 1990 1207
8. D. Descamps G. Collin I. Loussert-Ajaka HIV–1 group O sensitivity to antiretroviral drugs AIDS 9 1995 977
9. F. Gao D.L. Robertson S.G. Morrison The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin J Virol 70 1996 7013
10. M. Goodenow T. Huet W. Saurin HIV–1 isolates are rapidly evolving quasispecies: Evidence of viral mixtures and preferred nucleotide substitutions J AIDS 2 1989 344
11. L.G. Gurtler P.H. Hauser J. Eberle A new subtype of human immunodeficiency virus type I (MVP–5180) from Cameroon J Virol 68 1994 1581
12. L.G. Gurtler L. Zekeng F. Simon Reactivity of five anti-HIV–1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots J Virol Methods 51 1995 177
13. L. Heyndrickx A.M. Janssens N. Davo HIV–1 group O and group M dual infection in Benin Lancet 347 1996 902
14. D.D. Ho A.U. Neumann A.S. Perelson Rapid turnover of plasma virions and CD4 lymphocytes in HIV–1 infection Nature 373 1995 123
15. R.M. Howell J.E. Fitzgibbon M. Noe In vivo sequence variation of the human immunodeficiency virus type 1 env gene: Evidence for recombination among variants found in a single individual AIDS Res Hum Retroviruses 7 1991 869
16. W. Janssens K. Fransen I. Loussert-Ajaka Diagnosis of HIV–1 group O infection by polymerase chain reaction Lancet 346 1995 451
17. T.O. Jonassen K. Stene-Johansen E.S. Berg Sequence analysis of HIV–1 group O from Norwegian patients infected in the 1960s Virology 231 1997 43
18. P.J. Kanki K.M. DeCock Epidemiology and natural history of HIV–2 AIDS 8 suppl 1 1994 S85
19. T. Leitner Genetic subtypes of HIV–1 G. Myers B. Korber B. Foley Human Retroviruses and AIDS 1996 1996 New Mexico, Los Alamos National Laboratory Los Alamos 28 Section III
20. I. Loussert-Ajaka M.-L. Chaix B. Korber Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France J Virol 69 1995 5640
21. I. Loussert-Ajaka T.D. Ly M.L. Chaix HIV–1/HIV–2 seronegativity in HIV–1 subtype O infected patients Lancet 343 1994 1393
22. L.M. Mansky H.M. Temin Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase J Virol 69 1995 5087
23. R. Marlink P. Kanki I. Thior Reduced rate of disease development after HIV–2 infection as compared to HIV–1 Science 265 1994 1587
24. P. Mauclere I. Loussert-Ajaka F. Damond Serological and virological characterization of HIV–1 group O infection in Cameroon AIDS 11 1997 445
25. G. Myers Tenth anniversary perspectives on AIDS. HIV: Between past and future AIDS Res Hum Retroviruses 10 1994 1317
26. G. Myers B. Korber S. Wain-Hobson Human retroviruses and AIDS 1993 1993 Los Alamos National Laboratory Los Alamos, New Mexico 68 Section III
27. C.P. Pau D.J. Hu C. Spruill Surveillance for human immunodeficiency virus type 1 group O infections in the United States Transfusion 1996 1996 36
28. M. Peeters A. Gueye S. Mboup Geographical distribution of HIV–1 group O viruses in Africa AIDS 11 1997 493
29. M. Rayfield K. DeCock W. Heyward Mixed human immunodeficiency virus (HIV) infection in an individual: Demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction J Infect Dis 158 1988 1170
30. M.A. Rayfield P. Sullivan C.I. Bandea HIV–1 group O virus identified for the first time in the United States Emerging Infectious Diseases 2 1996 209
31. R.A. Respess A. Butcher H. Wang Detection of genetically diverse human immunodeficiency virus type 1 group M and O isolates by PCR J Clin Microbiol 35 1997 1284
32. D.L. Robertson P.M. Sharp F.E. McCutchan Recombination in HIV–1 Nature 374 1995 124
33. C. Schable L. Zekeng C.-P. Pau Sensitivity of United States HIV antibody tests for detection of HIV–1 group O infections Lancet 344 1994 1333
34. P.M. Sharp D.L. Robertson F. Gao Origins and diversity of human immunodeficiency viruses AIDS 8 suppl 1 1994 S27
35. F. Simon T.D. Ly A. Baillou-Beaufils Sensitivity of screening kits for anti-HIV–1 subtype O antibodies AIDS 8 1994 1628
36. Simon OF, Mauclere P, Fagot P, et al: Virological and serological characterization of HIV–1 group O [abstract 30]. In Program and Abstracts of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1997, p 70
37. J. Takehisa L. Zekeng T. Miura Triple HIV–1 infection with group O and group M of different clades in a single Cameroonian AIDS patient J Acquir Immune Defic Syndr Hum Retrovirol 14 1997 81
38. J. van Binsbergen D. de Rijk H. Peels Evaluation of a new third generation anti-HIV–1/anti-HIV–2 assay with increased sensitivity for HIV–1 group O J Virol Methods 60 1996 131
39. M. Vanden Haesevelde J.-L. Decourt R.J. De Leys Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate J Virol 68 1994 1586
40. X. Wei S.K. Ghosh M.E. Taylor Viral dynamics in human immunodeficiency virus type 1 infection Nature 373 1995 117
41. WHO Network for HIV Isolation and Characterization HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains AIDS Res Hum Retroviruses 10 1994 1327
42. T. Zhu N. Wang A. Carr Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconverter J Virol 691 1995 324